Pfizer Will Again Seek OK for Remoxy Pain Drug

Pfizer plans to continue petitioning the FDA for approval of its pain drug Remoxy. The drugmaker promised new clinical trials, comparing a newer version of the drug to an older one and also evaluating its potential for abuse.
BusinessWeek